To study the effect of different anaesthetic methods on pediatric neurocognitive development
and cerebral injury during pediatric living related liver transplantation .
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT03024840
Ages eligible for Study
4 Months to 12 Months
Genders eligible for Study
Accepts Healthy Volunteers
Children with end-stage liver disease Children with biliary atresia
pre-existing cerebral disease second liver transplantation
All locations for NCT03024840
No.24 Fukang Road,Nankai District
Tianjin, Tianjin, China, 300192
View full eligibility
Tris trial is registered with FDA with number: NCT03024840. The sponsor of the trial is Tianjin First Central Hospital and it is looking for 60 volunteers for the current phase.
Official trial title: The Effect of Sevoflurane or Propofol on Brain Injury and Neurocognitive in Pediatric Living Related Liver Transplantation
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Thank you for applying!
We'll contact you soon with more information.
Consult your doctor?
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.